がんとは何ですか?

Cancer develops when unrepaired genetic mutations allow a cell to divide faster and survive longer than surrounding cells. Although DNA repair enzymes fix most mutations, some remain unchecked. Over time, these mutant cells proliferate and form tumors. Understanding how cancers originate from somatic mutations in a single cell is fundamental to cancer research and treatment development.

Benign tumors remain confined to their tissue of origin, are typically harmless, and can be surgically removed. Malignant tumors, however, can break away from the primary site, invade distant tissues, and form new tumors through metastasis. This invasive capability distinguishes malignant tumors as cancerous and makes them significantly more dangerous to organism survival.

Metastasis is the process by which malignant tumor cells break off from the primary site and invade distant tissues to form secondary tumors. This hallmark of cancerous tumors allows cancer to spread throughout the body. The epithelial mesenchymal transition and metastasis represent critical mechanisms enabling cancer cells to migrate and establish colonies in new locations.

Cancer can arise in nearly any body tissue. Leukemia results from uncontrolled white blood cell proliferation, colon cancer develops from unhindered growth of large intestine cells, and sarcoma arises from abnormal division of soft tissues including tendons, cartilage, and muscles. Each cancer type reflects the specific cell population that becomes malignant.

Cell lines are immortalized cells derived from cancer patients that effectively replicate indefinitely in laboratory settings. Common examples include HeLa, OVCAR-3, and LNCaP cell lines. Researchers use these standardized cell lines across laboratories to understand cancer pathology, facilitate drug discovery, and test drug efficacy and toxicity efficiently.

Transgenic, knockout, and knock-in mouse models have been developed to study cancer onset and progression in living organisms. These models allow researchers to observe how genetic alterations lead to tumor development and to test how potential treatments affect cancer growth. Mouse models bridge the gap between cell culture studies and human cancer treatment.

Cancer cells exhibit two heritable characteristics: they reproduce in defiance of normal cell growth and division regulation, and they invade and colonize territories of other cells and tissues. These traits result from genetic alterations, particularly mutations in cell cycle regulation genes that allow cancerous cells to divide at the expense of neighboring cells.